CB

Coagulare Biomedica

Europe, Buckinghamshire, United Kingdom, Beaconsfield

Description

Coagulare Biomedica

Investor Profile

Coagulare Biomedica has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series Unknown (100%)

Country Focus

  • United Kingdom (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Coagulare Biomedica frequently co-invest with?

Lancaster Capital
Europe, Glasgow City, United Kingdom, Glasgow
Co-Investments: 1
Kelvin Capital
Europe, Glasgow City, United Kingdom, Glasgow
Co-Investments: 1
Scottish Enterprise
Europe, Glasgow City, United Kingdom, Glasgow
Co-Investments: 1
Ingenza
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 1

What are some of recent deals done by Coagulare Biomedica?

ProFactor Pharma

Newhouse, North Lanarkshire, United Kingdom

ProFactor Pharma provides commercialise and supply recombinant blood factors for the treatment of haemophilia.

BiotechnologyHealth CareMedical
Series UnknownMar 21, 2015
Amount Raised: $137,572